~~<i id='C87664F9D0'><strike id='C87664F9D0'><tt id='C87664F9D0'><pre id='C87664F9D0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：comprehensive 2025-09-09 19:28:25 - browse：1

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Assistant physicians can help address the primary care shortage

leisure time

Wikipedia

entertainment

explore

focus

hotspot

AdobeThefederalgovernmentisagainofferingfreeCovid-19teststoAmericans,providingafifthroundoffreetests

WSS

Grad students accuse University of California of wage theft

Climate activists disrupt London Pride march to protest corporate sponsorship

PBMs drew scrutiny in House hearing — and so did pharma

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Does Medicare's free annual wellness visit do any good?

focus

comprehensive

leisure time

Hollywood unions extend contract negotiations for actors

Chamber of Commerce, DOJ clash in court over drug prices

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Drug repurposing or repositioning? The language matters

'Cuddling' is just what the doctor ordered for a 200

Anesthesiologist group: stop taking Ozempic before surgery

Midwives could help bridge maternal health disparities in the U.S.

Activists slam private health insurers over coverage restrictions

Patients, doctors press FTC to beef up hospital merger scrutiny

Wikipedia

Russian court extends detention of American musician

FDA panel to weigh safety of artificial wombs for preterm births

'A game

Assistant physicians can help address the primary care shortage

Medical schools are missing the mark on artificial intelligence

New company forms to vet health AI models, root out weaknesses

entertainment

explore

focus

hotspot